198Au-labeled hydroxymethyl phosphines as models for potential therapeutic pharmaceuticals.
The development of novel gold-198 complexes with water-soluble phosphines is reported. A series of cationic and hydrophilic 198Au complexes containing the ligands tris(hydroxymethyl)phosphine (THP, 1) 1,2-bis[bis(hydroxymethyl)phosphino]benzene (HMPB, 2), and 1,2-bis[bis(hydroxymethyl)phosphino]ethane (HMPE, 3) were prepared and evaluated as models for potential gold-199 radiopharmaceuticals. The 198Au complexes were formed in high radiochemical purity by simply mixing H198AuCl4 with the respective ligand. The complexes were shown to exhibit high in vitro stability over wide pH ranges and temperatures. However, only the 198Au(HMPB)2+ complex was found to exhibit good in vivo stability. HPLC analyses indicated that the 198Au complexes with these three phosphine ligands produced singular species with similar retention times as compared to their known macroscopic complexes.
Berning
D E
DE
Center for Radiological Research, Department of Chemistry, University of Missouri, Columbia 65203, USA. dberning@nrel.nrel.gov
Katti
K V
KV
Volkert
W A
WA
Higginbotham
C J
CJ
Ketring
A R
AR
D000818:Animals; D004355:Drug Stability; D006050:Gold Radioisotopes / Q000737:chemistry* / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007553:Isotope Labeling; D010720:Phosphines / Q000138:chemical synthesis* / Q000493:pharmacokinetics / Q000627:therapeutic use; D019275:Radiopharmaceuticals / Q000737:chemistry* / Q000627:therapeutic use; D051381:Rats; D017207:Rats, Sprague-Dawley; D014018:Tissue Distribution
D006050:Gold Radioisotopes; D010720:Phosphines; D019275:Radiopharmaceuticals